126 related articles for article (PubMed ID: 3298136)
1. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
Bergsagel DE; Haas RH; Messner HA
Invest New Drugs; 1987; 5 Suppl():S9-17. PubMed ID: 3298136
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
Bergsagel DE; Haas RH; Messner HA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):29-34. PubMed ID: 3464099
[TBL] [Abstract][Full Text] [Related]
3. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
Bergsagel DE; Messner H
Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2b in the management of chronic granulocytic leukemia.
Bergsagel DE
Cancer Treat Rev; 1988 Jan; 15 Suppl A():15-20. PubMed ID: 3422593
[No Abstract] [Full Text] [Related]
5. Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.
Niederle N; Kloke O; May D; Becher R; Osieka R; Schmidt CG
Invest New Drugs; 1987; 5 Suppl():S19-25. PubMed ID: 3474219
[TBL] [Abstract][Full Text] [Related]
6. Interferon alfa-2b in the treatment of chronic myelogenous leukemia.
Niederle N; Kloke O; Osieka R; Wandl U; Opalka B; Schmidt CG
Semin Oncol; 1987 Jun; 14(2 Suppl 2):29-35. PubMed ID: 3473689
[TBL] [Abstract][Full Text] [Related]
7. Interferons in the treatment of multiple myeloma.
Cooper MR; Welander CE
Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
[TBL] [Abstract][Full Text] [Related]
8. [Busulfan versus busulfan-interferon as maintenance therapy in chronic myeloid leukemia].
López Hernández MA; Flores-Chapa JD; Trueba Christy E; Borbolla Escoboza JR; Carrillo Rosales T
Rev Invest Clin; 1996; 48(4):281-7. PubMed ID: 8966391
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel RJ
Invest New Drugs; 1987; 5 Suppl():S41-6. PubMed ID: 3597002
[TBL] [Abstract][Full Text] [Related]
10. Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugs.
Welander CE
Invest New Drugs; 1987; 5 Suppl():S47-59. PubMed ID: 3298133
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inveradi D; Bernasconi P; Mancini M; Grignani F; Bernasconi C
Cancer Treat Rev; 1988 Jan; 15 Suppl A():21-6. PubMed ID: 3277708
[No Abstract] [Full Text] [Related]
12. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
Hansson J; Aamdal S; Bastholt L; Brandberg Y; Hernberg M; Nilsson B; Stierner U; von der Maase H;
Lancet Oncol; 2011 Feb; 12(2):144-52. PubMed ID: 21256809
[TBL] [Abstract][Full Text] [Related]
13. [Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)].
Khoroshko ND; Turkina AG; Zakharova AV; Kobzev IuN; Domracheva EV; Tikhonova LIu; Semenova EA; Zhuravlev VS; Sokolova MA; Kuznetsov SV
Ter Arkh; 1999; 71(7):42-7. PubMed ID: 10481867
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b.
Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Falcoff E; Schwab D; Lerminier M; Pouillart P
Invest New Drugs; 1987; 5 Suppl():S61-3. PubMed ID: 3597003
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897].
Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H
Onkologie; 1988 Feb; 11(1):25-9. PubMed ID: 3283622
[TBL] [Abstract][Full Text] [Related]
16. Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.
Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H
Blut; 1988 Feb; 56(2):87-91. PubMed ID: 3277680
[TBL] [Abstract][Full Text] [Related]
17. Interferons in the treatment of multiple myeloma.
Cooper MR
Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
[TBL] [Abstract][Full Text] [Related]
18. Interferon in the treatment of hairy cell leukemia.
Thompson JA; Fefer A
Cancer; 1987 Feb; 59(3 Suppl):605-9. PubMed ID: 3542183
[TBL] [Abstract][Full Text] [Related]
19. The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study.
Thompson JA; Fefer A
Invest New Drugs; 1987; 5 Suppl():S5-8. PubMed ID: 3298134
[TBL] [Abstract][Full Text] [Related]
20. [A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan].
Matsuo T; Tomonaga M; Kuriyama K; Jinnai I; Jubashi T; Nonaka H; Kohno T; Tsukasaki K; Atogami S; Itoyama T
Rinsho Ketsueki; 1989 May; 30(5):625-30. PubMed ID: 2795875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
